Becker Richard A, Borgert Christopher J, Webb Simon, Ansell Jay, Amundson Sara, Portier Christopher J, Goldberg Alan, Bruner Leon H, Rowan Andrew, Curren Rodger D, Stott William T
American Chemistry Council, Arlington, VA, USA.
Regul Toxicol Pharmacol. 2006 Oct;46(1):18-22. doi: 10.1016/j.yrtph.2006.06.001. Epub 2006 Jul 28.
The workshop objectives were to explore progress in implementing new, revised and alternative toxicological test methods across regulatory evaluation frameworks and decision-making programs in the United States, to identify barriers and to develop recommendations to further promote adoption of approaches that reduce, refine, or replace the use of animal methods. The workshop included sessions on: (1) current research, development, and validation of alternative methods within the U.S. federal government; (2) emerging alternative methodologies with potential applications to a broad spectrum of toxicity evaluation strategies; (3) tiered evaluation ("intelligent testing") strategies; and (4) identification of, and recommendations to address, critical barriers that affect adoption and use of new, revised alternative toxicological test methods by U.S. regulatory agencies. Through facilitated discussion, a list of barriers and recommendations were developed and grouped into categories of economic/financial, scientific/technical, and regulatory/policy. Overall, participants from all sectors collectively supported catalyzing actions to promote more meaningful and rapid progress for research to develop alternative methods focused for use in regulatory programs, accelerated lab investigations to validate such alternative methods and adoption of regulatory frameworks which embrace and incorporate these validated alternatives.
本次研讨会的目标是探讨在美国的监管评估框架和决策程序中实施新的、修订的和替代的毒理学测试方法方面的进展,识别障碍,并提出建议以进一步推动采用能够减少、优化或替代动物实验方法的途径。研讨会包括以下几个环节:(1)美国联邦政府内部替代方法的当前研究、开发和验证;(2)具有广泛毒性评估策略潜在应用的新兴替代方法;(3)分层评估(“智能测试”)策略;以及(4)识别影响美国监管机构采用和使用新的、修订的替代毒理学测试方法的关键障碍并提出应对建议。通过深入讨论,制定了一份障碍和建议清单,并将其分为经济/财务、科学/技术和监管/政策几类。总体而言,来自各个部门的参与者共同支持采取行动,以促进在开发用于监管项目的替代方法的研究方面取得更有意义和更快的进展,加速实验室调查以验证此类替代方法,并采用包含并纳入这些经过验证的替代方法的监管框架。